๐ก๐ฒ๐๐ ๐ฆ๐๐บ๐บ๐ฎ๐ฟ๐
โข Lupin Limited has launched the world's first fixed-dose triple combination drug for the treatment of chronic obstructive pulmonary disease in India.
โข The product will be available in a single-strength fixed dose, with a recommended once-daily dosage.
โข India has more than 37 million individuals struggling with COPD, making it a leading cause of death and disability in the nation.